News About: Pharm. Industry
73 percent of psychiatrists say reimbursement restriction of Zyprexa is improper
73 percent of psychiatrists said the reimbursement restriction of Zyprexa (olanzapine), schizophrenia medication, is unfair, a survey showed recently.
According to a survey conducted on 100 psychiatrists nationwide...
Osong International Bio Exposition 2002 lures many foreign investors in biotechnology field
With the opportunity to open the Bio Expo Korea 2002, which is being held for a month-long period (September 25 through October 24, 2002), a number of foreign investors in the biotechnology field will visit Korea to t...
HIRA to curb NHI payment on Zyprexa
The Health Insurance Review Agency (HIRA) decided to control the NHI payment on Zyprexa, a major tranquilizer (E. Lilly) by classifying it as the 2nd choice of drugs, on the ground that it had no any significant diffe...
Sales of 99 pharmaceutical firms total 3.420 trillion won in first half
According to statistics compiled by the Korea Tax Union (KTU), the combined sales of the 99 pharmaceutical firms and the 92 drug wholesalers marked 3.421 trillion won and 1.630 trillion won, respectively, in t...
KPMA backlashes against government's tax incentive reduction.
The KPMA sensitively concerned about the government's tax incentive policy of intending to reduce over the new drug R&D, and earnestly urged them to withdraw its policy.
The KPMA presented a recommendation letter t...
Dongwha Pharm evaluated as Korea's oldest bioengineering firm, a book says
Dongwha Pharm is the oldest bioengineering firm in Korea heralding a new era of the domestic pharmaceutical firms with a foundation motto for the people's health, according to a book titled " Ethics-based management m...
Foreign-invested pharmaceutical firms snatched up 16 reimbursed medicines exceeding 10.0 billion won
Of 30 reimbursed medicines exceeding 10.0 billion won in 2001, foreign-invested pharmaceutical firms accounted for 16 items, Rep. Kim Hong-shin said during the recent parliamentary inspection to Health Insurance...
Drug wholesalers expressing dissatisfaction over discontinuation of money-collection discount
Now that some pharmaceutical firms have frequently reduced a drug wholesaler's margin and even discontinued the offering of special discounts during payment collection from the drug wholesaler, the wholesaling industr...
Frequent changes in company names of multinationals confuse domestic medical providers
The renowned company names of some multinationals in Korea, such as Upjohn Korea, Searle-Ciba Geigy Korea, Rhone-Poulene Rorer Korea, and Sandoz Korea, have been changed and disappeared.
Pharmaceutical business so...
Foreign-invested pharmaceutical firms remain concerned about successive cost cutting measures
In parallel with a series of the government measures aimed at reducing pharmaceutical spending for better finance stability in the National Health Insurance Corp., including a drug price re-evaluation system, a minimu...
